Paris, France

Clément Nizak


 

Average Co-Inventor Count = 7.9

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Clément Nizak: Innovating Oncology Diagnosis**

Introduction

Clément Nizak is a prominent inventor based in Paris, France, known for his significant contributions to the field of biological diagnosis in oncology. With a total of two patents to his name, Nizak is at the forefront of developing innovative methods and apparatuses aimed at improving cancer detection and characterization.

Latest Patents

Nizak's most recent patents include a **Method for Detecting and/or Characterising Tumour Cells and Associated Apparatus**. This invention focuses on the biological diagnosis in oncology, specifically targeting the detection and characterization of tumor cells through the analysis of the tumor cell secretome, including specific peptides, proteins, and tumor markers. Additionally, he has developed a **Method of Analyzing the Content of Drops and Associated Apparatus**, which involves measuring a physical parameter characteristic of the attachment of the target element to an aggregate—pivotal for the analysis of various biological samples.

Career Highlights

Clément Nizak has worked with notable institutions, including the Ecole Supérieure de Physique et de Chimie Industrielles de la Ville de Paris and the Chu Montpellier. His work at these establishments has allowed him to collaborate with fellow researchers and refine his innovations in the medical field.

Collaborations

Throughout his career, Nizak has collaborated with esteemed professionals such as Andrew David Griffiths and Raphaël Clément Li-Ming Doineau. These collaborations have played a vital role in enhancing the quality and efficacy of his patented inventions, further advancing the diagnostics in oncology.

Conclusion

Clément Nizak stands out as a visionary inventor in the realm of oncology, with a firm commitment to enhancing medical diagnostics. His innovative approaches through patented methodologies not only showcase his expertise but also hold promise for better detection and analysis of tumor cells, ultimately contributing to improved patient outcomes in cancer care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…